Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - betamethasone valerate - cutaneous ointment - 1mg/1gram

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - betamethasone valerate - cutaneous ointment - 1mg/1gram

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - betamethasone valerate - cutaneous ointment - 1mg/1gram

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - betamethasone valerate - cutaneous ointment - 1mg/1gram

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - betamethasone valerate - cutaneous cream - 250microgram/1gram

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - betamethasone valerate - cutaneous ointment - 250microgram/1gram

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - betamethasone valerate - cutaneous ointment - 1mg/1gram

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

physicians total care, inc. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

teligent pharma, inc. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone dipropionate  lotion is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older. betamethasone dipropionate lotion is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation. risk summary there are no available data on betamethasone dipropionate lotion use in pregnant women to identify a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of greater than 300 grams of potent or very potent topical corticosteroid during a pregnancy. advise pregnant women that betamethasone dipropionate lotion may increase the risk of having a low birthweight infant and to use betamethasone dipropionate lotion on the smallest area of skin and for the shortest duration possible.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

teligent pharma, inc. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone dipropionate ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older. betamethasone dipropionate ointment is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation. risk summary there are no available data of betamethasone dipropionate ointment use in pregnant women  to identify a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of greater than 300 grams of potent or very potent topical corticosteroid during a pregnancy. advise pregnant women that betamethasone dipropionate ointment may increase the risk of having a low birthweight infant and to use betamethasone dipropionate ointment on the smallest area of skin and for the shortest durat